Imunon (IMNN) Cash & Equivalents (2010 - 2026)
Imunon (IMNN) posted Cash & Equivalents of $4.79 million for Q1 2026, up 66.9% from $2.87 million a year earlier but down 45.4% from the prior quarter.
Powered by 
Analysis
Imunon (IMNN) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Imunon's Cash & Equivalents came in at $8.78 million, up 49.5% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- In prior years, Imunon's Cash & Equivalents was $5.87 million in FY2024 (+0.6%), $5.84 million in FY2023 (-49.2%), $11.49 million in FY2022 (-41.3%) and $19.59 million in FY2021 (+14.1%).
- Quarterly Cash & Equivalents has run from a low of $2.35 million in Q1 2024 to a high of $28.36 million in Q1 2022 over five years.
- On a year-over-year basis, Cash & Equivalents increased in four of the last six quarters, with growth averaging 18.1%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2026, with growth of 66.9%; the weakest was Q1 2024, with a decline of 77.4%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $8.78 million (Q4 2025), $5.25 million (Q3 2025) and $4.73 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Imunon | 6.16 Mn | 6.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.79 Mn |
| Dec 31, 2025 | 8.78 Mn |
| Sep 30, 2025 | 5.25 Mn |
| Jun 30, 2025 | 4.73 Mn |
| Mar 31, 2025 | 2.87 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Jun 30, 2024 | 5.31 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Sep 30, 2023 | 12.88 Mn |
| Jun 30, 2023 | 6.61 Mn |
| Mar 31, 2023 | 10.40 Mn |
| Dec 31, 2022 | 11.49 Mn |
| Sep 30, 2022 | 26.94 Mn |
| Jun 30, 2022 | 26.74 Mn |
| Mar 31, 2022 | 28.36 Mn |
| Dec 31, 2021 | 19.59 Mn |
| Sep 30, 2021 | 25.65 Mn |
| Jun 30, 2021 | 26.44 Mn |
| Mar 31, 2021 | 37.76 Mn |
API Access
Imunon Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();